Melanoma Death Rates Falling Fast Thanks to Immunotherapy
Elisa Becze BA, ELS
Voice
Description
Two-year survival rates for patients with advanced melanoma increased quickly after the introduction of ipilimumab in 2011, according to an analysis published the journal Cancer.